机译:曲妥珠单抗与EGFR / HER-2酪氨酸激酶抑制剂在HER-2阳性乳腺癌细胞中的协同相互作用
National Institute for Cellular Biotechnology, Dublin City University, Dublin, 9, Ireland;
Department of Physiology &amp Medical Physics, Royal College of Surgeons in Ireland, Dublin, 18, Ireland;
UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, 4, Ireland;
UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, 4, Ireland;
UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, 4, Ireland;
National Institute for Cellular Biotechnology, Dublin City University, Dublin, 9, Ireland;
Breast tumour; ErbB2; Epidermal growth factor receptor; Gefitinib; Herceptin; Lapatinib;
机译:曲妥珠单抗与EGFR / HER-2酪氨酸激酶抑制剂在HER-2阳性乳腺癌细胞中的协同相互作用。
机译:蛋白酪氨酸磷酸酶SHP-1通过调节EGFR和HER-2的磷酸化使EGFR / HER-2阳性乳腺癌细胞对曲妥珠单抗敏感
机译:肺癌细胞系对EGFR选择性酪氨酸激酶抑制剂ZD1839('Iressa')的敏感性与EGFR或HER-2的表达或K-ras基因状态无关。
机译:酪氨酸激酶抑制剂抗性乳腺癌细胞赖氨酸乙酰化和琥珀酸抗蛋白酶磷酸化的分析和串扰
机译:荧光原位杂交(FISH)检测HER-2 / neu对曲妥珠单抗治疗转移性乳腺癌的影响。
机译:蛋白酪氨酸磷酸酶SHP-1通过调节EGFR和HER-2的磷酸化使EGFR / HER-2阳性乳腺癌细胞对曲妥珠单抗敏感
机译:蛋白酪氨酸磷酸酶SHP-1通过调节EGFR和HER-2的磷酸化来使EGFR / Her-2正乳腺癌细胞敏感到曲妥珠单抗
机译:对接受曲妥珠单抗的IV期HER2阳性乳腺癌患者施用HER-2 / neu胞内域肽基疫苗的II期研究